XML 26 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) (USD $)
3 Months Ended 11 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Jul. 03, 2006
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Acquired share capital of Bio-Maxtrix Scientific Gruop, Inc.     100.00%
Consideration of shares of common stock of the Company     10,000,000
Cancellation of shares of the Company owned and held by John Lauring     10,000,000
Percent of voting capital stock of the Company held by former stockholder of BMSG     80.00%
Shares of Entest BioMedical, Inc. for Securities Available for Sale 10,000,000    
Established valuation allowance 100.00%    
Advertising expenses $ 0 $ 0